共 95 条
[1]
Houwing M(2019)Sickle cell disease: clinical presentation and management of a global health challenge Blood Reviews 37 100580-1048
[2]
de Pagter P(2014)Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members JAMA 312 1033-473
[3]
van Beers E(2011)Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: a systematic literature review International Orthopaedics 2011 465-164
[4]
Biemond B(2012)Osteoarticular involvement in sickle cell disease Revista Brasileira de Hematologia e Hemoterapia 34 156-308
[5]
Rettenbacher E(2008)Total THA in adult osteonecrosis related to sickle cell disease Clinical Orthopaedics and Related Research 2008 300-481
[6]
Rijneveld A(2018)Noncemented total hip arthroplasty in sickle-cell disease: long-term results The Journal of arthroplasty 33 477-161
[7]
Schols EM(2002)Total hip replacement in sickle cell disease International Orthopaedics 26 157-192
[8]
Philipsen JNJ(2016)Cementless total hip replacements in sickle cell disease Hip International 26 186-S207
[9]
Tamminga RYJ(2011)Measures of hip function and symptoms: Harris Hip Score (HHS), Hip Disability and Osteoarthritis Outcome Score (HOOS), Oxford Hip Score (OHS), Lequesne Index of Severity for Osteoarthritis of the Hip (LISOH), and American Academy of Orthopedic Surgeons (AAOS) Hip and Knee Questionnaire Arthritis Care Research (Hoboken) 63 S200-1632
[10]
van Draat KF(2016)Clinically important improvement thresholds for Harris Hip Score and its ability to predict revision risk after primary total hip arthroplasty BMC Musculoskeletal Disorders 17 256-298